Blue Jet Healthcare · NSE: BLUEJET · BSE: 544009
Q4 FY25 results · Jan–Mar 2025
Blue Jet Healthcare reported revenue from operations of ₹340.44 crore (up 85.1% from Q4 FY24) and net profit of ₹110.09 crore (up 178.8% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a standalone basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 340.44 | 183.94 | +85.1% | 318.38 | +6.9% |
| Other income | 12.22 | 8.83 | +38.4% | 13.24 | −7.7% |
| Total income | 352.67 | 192.78 | +82.9% | 331.62 | +6.3% |
| Profit before tax | 147.21 | 54.15 | +171.9% | 132.49 | +11.1% |
| Net profit for the period | 110.09 | 39.49 | +178.8% | 98.98 | +11.2% |
| EPS, basic (₹) | 6.35 | 2.29 | +177.3% | 5.71 | +11.2% |
| Net margin (%) | 32.3 | 21.5 | 31.1 |
Standalone
- Filed with BSE
- 14 May 2025, 17:02 IST
- Board meeting
- 14 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE